Insights into Editorial: New approach to drug delivery combines biologics and antibody-drug conjugates
Context: A type of nanoparticle designed by researchers from University of Massachusetts, Amherst, in the U.S., embodies a new approach to treating diseases that could potentially revolutionise the field. This combines concepts of biologics and antibody–drug conjugates to produce protein–antibody conjugates that can be used for targeted drug delivery in the case of pancreatic …